Vita Coco Company, Inc. (COCO) director sells 10,000 shares under plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of 10,000 shares of common stock on March 16, 2026 at a weighted average price of $60.137 per share. The sale was effected under a pre-arranged Rule 10b5-1 trading plan.
After this transaction, Sadowsky directly holds 594,366 shares of Vita Coco common stock. He also holds a fully vested, currently exercisable non-qualified stock option covering 27,300 shares of common stock at an exercise price of $10.178 per share, expiring on January 2, 2030.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
Net Seller: 10,000 shares ($601,370)
Net Sell
2 txns
Insider
Sadowsky Kenneth
Role
Director
Sold
10,000 shs ($601K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 10,000 | $60.137 | $601K |
| holding | Non-Qualified Stock Option (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Common Stock — 594,366 shares (Direct);
Non-Qualified Stock Option (Right to Buy) — 27,300 shares (Direct)
Footnotes (1)
- The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.19, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. The stock option is fully vested and currently exercisable.
FAQ
What insider transaction did Vita Coco (COCO) director Kenneth Sadowsky report?
Kenneth Sadowsky reported selling 10,000 Vita Coco common shares. The sale occurred on March 16, 2026 at a weighted average price of $60.137 per share in open-market transactions executed under a Rule 10b5-1 trading plan.
Was the Vita Coco (COCO) insider sale by Kenneth Sadowsky under a Rule 10b5-1 plan?
Yes, the filing states the sale was made under a Rule 10b5-1 trading plan. Such plans are pre-arranged programs that schedule trades in advance, which can make the timing of transactions less indicative of an insider’s short-term view.
Does the Form 4 show any option exercises by Vita Coco (COCO) director Kenneth Sadowsky?
No option exercises are reported in this Form 4; only holdings are listed. The filing describes a fully vested non-qualified stock option for 27,300 underlying shares at a $10.178 exercise price that remains outstanding and exercisable through January 2, 2030.